CLINICAL ROLE -
Can the FDA Lower Drug Prices?
The pharmaceutical industry is facing increased scrutiny from lawmakers about the appropriateness of high drug prices.
Specialty Pharmacy Today: Improving the Lives of Patients With Rare Diseases Through Orphan Drug Management
The specialty pharmacy marketplace has quickly become the primary dispenser of most therapies for orphan conditions.
Where's the Special in Specialty? Has the Increase in the Number of Players Diluted Services?
The growing cost of specialty products places greater importance on the support that patients receive.
Biosimilars May Change the Treatment Landscape for Inflammatory Diseases
Brave New World: What the Trend Away From Fee-for-Service Means for Health-System Specialty Pharmacy
Properly managing reimbursement is critical to managing costs and outcomes in an evolving payment environment.
Key Points From USP
USP outlines new quality-of-practice standards for handling hazardous drugs that promote the safety of patients and health
Indispensable: Opportunities for Specialty Pharmacy to Deliver Value and Access
Value-based contracts among pharmaceutical manufacturers and payers have not achieved the success levels necessary to drive significant systemic change.
Better Value, Better Care: How Value-based Management Models Can Improve Health and Lower Costs in Specialty Pharmacy
The introduction of preferred formulary status for lower-cost generics was the first example of value-based pharmacy benefit management.
Differentiation: Separating From the Pack—The “MUST†Haves
Pharmacies that do not differentiate themselves and fail to provide must-have services will lose out to their competitors.
Considerations for Specialty Pharmacy as Enforcement on Controlled Substances Ramps Up to Counter Opioid Crisis
State regulators and legislatures are considering new requirements for controlled substance prescribing and reporting.